Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Non-cash Items (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Non-cash Items data on record, last reported at $2686.0 in Q3 2025.

  • For Q3 2025, Non-cash Items fell 95.91% year-over-year to $2686.0; the TTM value through Sep 2025 reached $2686.0, down 95.91%, while the annual FY2024 figure was $936.0, 99.64% down from the prior year.
  • Non-cash Items reached $2686.0 in Q3 2025 per TNXP's latest filing, up from $2294.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $892008.0 in Q1 2023 and bottomed at $936.0 in Q4 2024.
  • Average Non-cash Items over 3 years is $209743.9, with a median of $65691.0 recorded in 2024.
  • Peak YoY movement for Non-cash Items: plummeted 35.73% in 2024, then plummeted 99.69% in 2025.
  • A 3-year view of Non-cash Items shows it stood at $259991.0 in 2023, then crashed by 99.64% to $936.0 in 2024, then skyrocketed by 186.97% to $2686.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $2686.0 in Q3 2025, $2294.0 in Q2 2025, and $1784.0 in Q1 2025.